Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Time to Go Beyond the Initial Shock

Journal of the American College of Cardiology

Volumn 54, Issue 22, 2009, Pages 1993-2000

  Mishkin, Joseph D ^a   Saxonhouse, Sherry J ^a   Woo, Gregory W ^a   Burkart, Thomas A ^a   Miles, William M ^a   Conti, Jamie B ^a   Schofield, Richard S ^a   Sears, Samuel F ^b   Aranda Jr , Juan M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

appropriate shock; heart failure; implantable cardioverter defibrillator therapy; inappropriate shock

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; LISINOPRIL; METOPROLOL SUCCINATE; MEXILETINE; SOTALOL;

ALGORITHM; DEFIBRILLATOR; DISTRESS SYNDROME; ELECTRIC SHOCK; ELECTROCARDIOGRAPHY; EVALUATION; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INAPPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK; INCIDENCE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SECONDARY PREVENTION; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EQUIPMENT FAILURE; HEART FAILURE; HUMANS; PRIMARY PREVENTION; PROGNOSIS; QUALITY OF LIFE; SECONDARY PREVENTION; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 71949096960     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.07.039     Document Type: Review

References (53)

1. National Cardiovascular Data Registry. ICD Registry. http://www.ncdr.com/webncdr/ICD/Default.aspx Accessed February 27, 2009.
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 (2002) 1703-1719
4. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
5. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol 51 (2008) 2085-2105
6. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
7. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
8. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
9. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
10. Kuck KH, Cappato R, Siebels J, Ruppel. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 200;102:748-54.
11. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008) 1009-1017
12. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
13. Goldenberg I., Moss A.J., Hall W.J., et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 113 (2006) 2810-2817
14. Daubert J. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51 (2008) 1357-1365
15. Hurst T.M., Hinrichs M., Breidenbach C., Katz N., and Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 34 (1999) 402-408
16. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 288 (2002) 3115-3123
17. Sears S.F., Shea J.B., and Conti J.B. How to respond to an implantable cardioverter-defibrillator shock. Circulation 111 (2005) e380-e382
18. Gehi A.K., Mehta D., and Gomes J.A. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA 296 (2006) 2839-2847
19. Klein R.C., Raitt M.H., Wilkoff B.L., et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 14 (2003) 940-948
20. Germano J.J., Reynolds M., Essebag V., and Josephson M.E. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol 97 (2006) 1255-1261
21. Whang W., Mittleman M.A., Rich D.Q., et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators. Results from the Triggers of Ventricular Arrhythmias (TOVA) study. Circulation 109 (2004) 1386-1391
22. Hreybe H., Ezzeddine R., Barrington W., et al. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks. Am J Cardiol 97 (2006) 544-546
23. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358 (2008) 2667-2677
24. Israel C. How to avoid inappropriate therapy. Curr Opin Cardiol 23 (2008) 65-71
25. Swerdlow C.D., Ahern T., Chen P.S., et al. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 24 (1994) 416-424
26. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
27. Packer M., Coats A.J.S., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
28. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90 (1994) 1765-1773
29. Brodine W.N., Tung R.T., Lee J.K., et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 96 (2005) 691-695
30. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. The OPTIC study: a randomized trial. JAMA 295 (2006) 165-171
31. Gilliam III F.R. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing. J Cardiovasc Electrophysiol 17 (2006) 553-556
32. Gallik D.M., Ben-Zur U.M., Gross J.N., and Furman S. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 19 (1996) 1089-1094
33. Wathen M.S., DeGroot P.J., Sweeney M.O., et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 110 (2004) 2591-2596
34. Wilkoff B.L., Williamson B.D., Stern R.S., et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 52 (2008) 541-550
35. Vyas A.K., Guo H., Moss A.J., et al. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 769-773
36. Goldberger J.J., Subacius H., Schaechter A., et al. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1228-1233
37. Domanski M.J., Exner D.V., Borkowf C.B., Geller N.L., Rosenberg Y., and Pfeffer M.A. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 33 (1999) 598-604
38. McMurray J., Køber L., Robertson M., et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 45 (2005) 525-530
39. Greene H.L. Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy. Am J Cardiol 78 (1996) 61-66
40. Ferreira-González I., Dos-Subirá L., and Guyatt G.H. Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. Eur Heart J 28 (2007) 469-477
41. Bollman A. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Am J Cardiovasc Drugs 5 (2005) 371-378
42. Pacifico A., Hohnloser S.H., Williams J.H., et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 340 (1999) 1855-1862
43. Stevenson W.G., Wilber D.J., Natale A., et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction. Circulation (2008) 2273-2282
44. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357 (2007) 2657-2665
45. Aliot E.M., Stevenson W.G., Almendral J.M., et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm 6 (2009) 886-933
46. Doshi R.N., Daoud E.G., Fellows C., et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 16 (2005) 1160-1165
47. Israel C., and Barold S. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvas Electrocardiogr 12 (2007) 375-382
48. Carbucicchio C., Santamaria M., Trevisi N., et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators. Circulation 117 (2008) 462-469
49. Passman R., Subacius H., and Ruo B. Implantable cardioverter defibrillators and quality of life: results from the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation Study. Arch Internal Med 167 (2007) 2226-2232
50. Mark D.B., Anstrom K.J., Sun J.L., et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 359 (2008) 999-1008
51. Sears S.F., Serber E.R., Lewis T.S., et al. Do positive health expectations and optimism relate to quality of life outcomes in ICD patients?. J Cardiopulm Rehabil 24 (2004) 324-331
52. Sears S.F., Kovacs A.H., Conti J.B., and Handberg E. Expanding the scope of practice for cardiac rehabilitation: managing patients with implantable cardioverter defibrillators. J Cardiopulm Rehabil 24 (2004) 209-215
53. Sears S.F., Shea J.B., and Conti J.B. The cardiology patient page: how to respond to an ICD shock. Circulation 111 (2005) e380-e383